Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe history now includes a new revision entry v3.5.4; the previous entry v3.5.3 was removed.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page footer has been updated to reflect a newer ClinicalTrials.gov interface/release revision (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.5.2 is now listed as the latest entry, and Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.0%

- Check85 days agoChange DetectedThe Record History now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.0%

- Check114 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the government-funding notices along with the older Revision: v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.